Although entertainment, social connection, and gaming will drive the initial adoption of Virtual Reality technology, the deepest and most significant market for Virtual Reality technology will be in clinical care and in improving health and wellness.
We know from years of clinical research that VR can address and ameliorate the most difficult problems in healthcare – ranging from mood disorders such as anxiety and depression to Post Traumatic Stress Disorder, Addictions, Autism, Cognitive Aging, Neuro and Physical Rehabilitation.
The list of clinical interventions made possible by Virtual Reality technology is long. VR technology also facilitates clinical assessments and medical training, as well as providing for improved surgical skill training and procedure planning. Personal health and wellness can be improved by using VR to engender better nutrition, promote healthy lifestyles, and to reduce stress and anxiety. As the cost of healthcare rises, VR technology can serve as an effective telemedicine platform to reduce costs of care delivery, and improve clinical efficiency.
This presentation will provide an overview of how VR technology will impact medicine, clinical care, and personal health and wellness, and how it will help to facilitate the shift of medicine to direct personal care.
Walter Greenleaf, PhD is a research neuroscientist and medical product developer working at Stanford University. Walter is known internationally as an early pioneer in digital medicine and virtual environment technology. With over three decades of research and product development experience in the field of medical virtual reality technology, Walter is considered a leading authority in the field.
As a scientist and medical product developer, Walter’s focus has been on computer-supported clinical products, with a specific focus on virtual reality and digital health technology to treat Post-traumatic Stress Disorder, Anxiety Disorders, Traumatic Brain Injury and Stroke, Addictions, Autism, and other difficult problems in behavioral and physical medicine.
He has founded and managed several medical product companies, including Pear Therapeutics, Virtually Better, InWorld Solutions, Cognitive Leap, and Greenleaf Medical. Walter recently served as the Director for the Mind Division, Stanford Center on Longevity, where his focus was on advancing research on age-related changes in cognition. He is currently a Distinguished Visiting Scholar at Stanford University’s MediaX Program, and the Stanford Virtual Human Interaction Lab. In addition to his research at Stanford, Walter is and co-founder of Virtual Ventures and Cognitive Leap, Chief Science Advisor at Pear Therapeutics, and Director of Technology Strategy for the University of Colorado National Behavioral Health Innovation Center.
Follow VRTO on socials – @VRtoronto and #VRTO2023